Determinants and materno-fetal outcomes related to cesarean section delivery in private and public hospitals in low- and middle-income countries: a systematic review and meta-analysis protocol by unknown
PROTOCOL Open Access
Determinants and materno-fetal outcomes
related to cesarean section delivery in
private and public hospitals in low- and
middle-income countries: a systematic
review and meta-analysis protocol
Idrissa Beogo1,2*, Bomar Mendez Rojas3 and Marie-Pierre Gagnon4
Abstract
Background: Despite the well-established morbidity, mortality, long-term effects, and unnecessary extra-cost
burden associated with cesarean section delivery (CSD) worldwide, its rate has grown exponentially. This has
become a great topical challenge for the international healthcare community and individual countries. Estimated at
three times the acceptable rate as defined by the World Health Organization in 1985, the continued upward trend
has been fuelled by higher income countries. Some low- and middle-income countries (LMICs) have now taken the
lead, and the factors contributing to this situation are poorly understood. The expansion of the private healthcare
sector may be playing a significant role. Distinguishing between the public and private hospitals’ role is critical in
this investigation as it has not yet been approached. This review aims to systematically synthesize knowledge on
the determinants of the CSD rate rise in private and public hospitals in LMICs and to investigate materno-fetal and
materno-infant outcomes of CSD in perinatal period, between private and public hospitals.
Methods/design: We will include studies published in English, French, Spanish, and Portuguese since 2000, using
any experimental design, including randomized controlled trials (RCTs), non-RCTs, quasi-experimental, before and
after studies, and interrupted time series. Outcomes of interest are the determinants of CSD and materno-fetal and
materno-infant outcomes. We will only include studies carried out in private and public hospitals in LMICs. The
literature searches will be conducted in the following databases: MEDLINE, Embase, CINAHL, Cochrane database,
LILACS, and HINARI. We will also include unpublished studies in the gray literature (theses and technical reports).
Using the two-person approach, two independent review authors will screen eligible articles, extract data, and
assess risk of bias. Disagreements will be resolved through discussion with a third author. Results will be presented
as structured summaries of the included studies. If possible, a meta-analysis will be conducted and, subsequently,
an analysis for heterogeneity will be implemented.
Discussion: The proposed systematic review of the CSD rate rise will provide up-to-date evidence in regard to
differences in proportions, determinants, and materno-fetal and materno-infant outcomes in perinatal period,
between private and public hospitals in LMICs. We believe that this knowledge synthesis will help to shed light on
the evidence and support evidence-informed decision-making with a view to addressing the issue in LMICs.
Systematic review registration: PROSPERO CRD42016036871
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Background
Since 1985, the World Health Organization (WHO) has
set the “ideal” rate of cesarean section delivery (CSD) at
between 10 and 15% [1]. However, this has sounded like
a liberalization mantra, prompting heated risk/benefit
debates among scholars. There is a steep upward trend,
and half of the world’s countries exceed the 15% level
[2], with some reaching historically high rates. Once a
concern of high-income countries [3, 4], the lead is now
held by some low- and middle-income countries
(LMICs), regardless of the continent [5, 6]: urban China
(64.1%) [7], Colombia (43.4%), Dominican Republic
(56.4%), Egypt (51.8%), Iran (47.9%), and Brazil (55.6%;
80% for second deliveries―when the first was by cesar-
ean―and over 99% for third births―when the first two
were by cesarean) [6, 8] to cite a few.
CSD is a major surgical procedure and far from being
a harmless practice. It heightens the risk of major short-
and long-term maternal morbidity and mortality [9–13],
even in the case of elective CSD [14, 15]. A number of
studies, including randomized control trials (RCTs) and
systematic reviews, have underscored an increased likeli-
hood of many short- and long-term adverse effects in
mothers and babies [16, 17]. CSD upward growth has
turned it into a great topical challenge for the inter-
national healthcare community and individual countries’
healthcare systems [18], raising conflicting policy-making
priorities for governments. Nevertheless, higher CSD rate
is not correlated to more favorable materno-fetal out-
comes. On the contrary, a number of systematic reviews
[19, 20] have shown that, apart from emergencies and
some truly life-saving preventive circumstances with a
sound cost-benefit ratio, CSD is clearly fraught with
anomalous short-term immune responses (i.e., reduction
of inflammatory marker expression in the newborn in-
fant), a greater risk of developing immune diseases (such
as asthma, allergies, DM type 1, celiac disease), a higher
risk of cancer, and hematopoietic development problems.
From an economic perspective, the cost of “unnecessary”
CSDs performed worldwide is estimated at $2.32 billion,
while the cost of “excess” ones amounts to approximately
$432 million [2].
Within individual countries, variations in CSD rates
and/or neonatal outcomes were found between differ-
ent types of hospitals [21], in particular private versus
public hospitals [22–24]. Some have hypothesized that
this difference is associated with the hospital culture
[25] or the payment scheme [26]. Other sources point
to the role of supplier-side demand induction behavior
[27, 28]. From a consumer perspective, some authors
have suggested that women request to have an elective
CSD in the absence of clinical indications [29–32].
However, McCourt et al.’s critical review [33] found
that women’s preference for CSD varied only from 0.3
to 14%. This leaves room for other contributive factors,
namely supply-side intervention.
Current practice of CSD is largely based on surgeon
and institutional preference. One recent ecological study
conducted in southern Asia and sub-Saharan Africa as-
sociated low CSD rate with poor access to the healthcare
system, especially surgery; the wealthiest have higher
CSD rates in resource-constrained settings [34]. Supply-
side demand induction is often cited in the literature,
and increased CSD rate seems to be related to profes-
sional convenience [35]. Hospital ownership matters and
a meaningful difference are noted in CSD behavior be-
tween private and public hospitals [6]. Using a repeated
measurement design, a significant difference in CSD de-
cision was observed between private and public hospitals
in Brazil [23]. Similarly, in Brazil, one of the two most
significant contributing factors for CSD was giving birth
under the private health system (OR = 4.3; 95%CI 2.3–
9.0) [36]. Figures are even more striking in some other
studies. In Peru, the CSD rate has climbed to 52.9% in
private hospitals with a growth of 86.3% over a decade
following the health reform [37]. In Brazil, the CSD rate
among women attending private hospitals is significantly
higher than the average, culminating up to 86.2%, with
high toll paid by primiparous [38, 39].
Rationale
Numerous systematic reviews have been conducted on
CSD in LMICs, although to the best of our knowledge,
none has approached the difference in CSD determinants
and outcomes derived from public and private hospitals.
The issue of CSDs is currently a global health concern. Its
development in nascent private healthcare systems of
LMICs constitutes an additional challenge. Therefore, this
review will reveal what leads people to undergo a CSD in
private or public health system, including medical and so-
cioeconomic and demographic motives, whether the deci-
sion is shared or induced. It will further portray the
medical outcomes derived for the dyad infant-mother per-
spective. Finally, systematically synthesizing evidence on
the determinants and materno-fetal and materno-infant
outcomes related to CSD is due, in order to up-to-date
knowledge and support evidence-informed decision for
making on appropriate policy options. Furthermore, the
study focuses on LMICs.
Research aims
This systematic review intends to investigate the deter-
minants and the outcomes of CSD for the dyad
materno-fetal and materno-infant in perinatal period.
The research specific aims to be addressed are (1) to in-
vestigate the determinants of choosing a CSD between
private and public hospitals in LMICs and (2) to investi-
gate differences in materno-fetal and materno-infant
Beogo et al. Systematic Reviews  (2017) 6:5 Page 2 of 6
outcomes deriving from CSD in perinatal period be-
tween private and public hospitals in LMICs.
Methods
This review was registered in the International Prospective
Register of Systematic Reviews (PROSPERO), registration
number CRD42013004319, and follows the Cochrane Col-
laboration methods [40]. In this study, private providers
are defined as “all organizations and individuals working
outside the direct control of the state” [41]. They consist
of for-profit (FP) and non-for-profit providers (NFP); the
former are defined as benefit-focused and the latter in-
clude philanthropic medical institutions. Institutional
stewardship is further considered to complete the defin-
ition of the private healthcare sector, because in LMICs,
services delivered in the private sector may be publicly
financed—commonly in NFP [42].
Search strategy
Both published and unpublished studies will be ex-
amined. We will follow the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) guide
[43] for this review. The checklist of the PRISMA recom-
mendations is included as an additional file (see Additional
file 1). The search will be performed in English. An initial
exploratory search through MEDLINE will be undertaken
followed by an analysis of words taken from the titles, ab-
stracts, keywords, and common descriptors. A concept plan
will then be built with the identified keywords and descrip-
tors to run the search in the following four databases:
Ovid-Medline®, CINHAL, Cochrane database, and Embase.
Two other freely available databases, LILACS and HINARI,
which cover more LMIC research, will be screened. Unpub-
lished studies will be sought from clinical trial registers,
Google and Google Scholar, and conference proceedings.
Finally, we will look through additional references from
pertinent studies. Regardless of the setting, studies pub-
lished in English, French, Spanish, and Portuguese will be
included. Because of the vacuum in the literature on
this topic for LMICs, the study will cover the period
from January 1, 1990, to March 2016. The starting ref-
erence date (1990) was chosen to coincide with the
adoption of the WHO’s 1985 recommendation setting
the “ideal rate” for CSDs at 10 to 15%, assuming that a
period of 5 years is a reasonable time lag for countries
to implement this recommendation. The second reason
was the expansion of improving CSD technology, which
had started in the 1990s, in LMICs.
Types of studies included
This review will include quantitative studies. The study
design consists of any experimental study design, namely
RCTs, non-RCTs, before and after quasi-experimental,
and interrupted time series designs. Non-RCT studies
will include case-control, cohort, and cross-sectional
studies in which CSD is the primary outcome used.
Inclusion/exclusion criteria
Countries are listed as LMICs based on the World Bank
2016 classification [44]. We will select studies that in-
clude medically prescribed planned and unplanned
CSDs, done in accredited public or private healthcare
settings, and elective CSDs. In addition, primiparous as
well as multiparous, twin, and breech births will also be
included. However, we will exclude (1) utilization of ex-
perimental CSDs, (2) stillbirth CSDs, and (3) outreach
mass surgery (Table 1).
Types of comparisons
This review will compare the CSDs performed in private
versus public settings in LMICs. The study will extract
data concerning the outcome (morbidities, mortalities,
and medical complications) of CSDs as the primary out-
come, as well as the motivators conducive to undergoing
those CSD.
Determinant and outcome measurement
This review will examine the key characteristics of stud-
ies that may determine the high CSD rate. It includes (1)
the where (i.e., urban versus rural, as well as racial/cul-
tural/ethnic background); (2) the who (i.e., practitioner
characteristics, decision-making process); (3) the which
(i.e., ownership, financing system, payment scheme,
management system, and underlying philosophy); (4)
consumer characteristics (fertile age women, sociodemo-
graphic, economic status); and (5) obstetrical patterns
(i.e., parity, type, and quality of the pregnancy).
We will consider outcome measures as defined by the
“Outcomes of interest to the Cochrane consumers &
communication review group” [45]. Initially, primary
outcomes consist of materno-fetal and materno-infant
medical outcomes: (1) mortality, (2) morbidity, and (3)
observed complications. The secondary outcomes in-
clude (1) participants’ knowledge/understanding of the
risks of CSD procedures; (2) participants’ involvement in
decision-making and their satisfaction with the decision
taken; and (3) other outcomes: birth goal attainment,
quality of life, self-efficacy, and social functioning.
Data extraction and synthesis
We plan to use the Rayyan systematic reviews web appli-
cation to explore and filter searches for eligible studies.
Using the two-person approach, the first two authors, IB
and BRM, will independently conduct the initial screen-
ing of all titles and abstracts captured in the databases
to determine eligibility. Next, both results will be com-
pared in order to identify any discrepancies. In this sce-
nario, MPG, who is an experienced systematic review
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author and Cochrane group trainer, will intervene through
a discussion to conclude this selection phase. Secondly, all
pertinent references will be retained for a second round of
assessment of the full texts, and disagreement will be
resolved in the same fashion. If needed, we will contact au-
thors of primary studies, either to request missing informa-
tion or to clarify unclear data. Finally, the PRISMA flow
diagram will report quantitative and qualitative information
on the selection process.
Assessment of methodological quality
Given the importance of quality assessment on the
results of systematic reviews, the underlying meth-
odological quality of studies, and the transferability
of the results, we will assess each type of design sep-
arately. The Cochrane Risk of Bias tool [46] will be
used to guide the assessment of RCT studies. Non-
RCTS deemed eligible for inclusion will be appraised
using the Joana Briggs Institute’s Qualitative Assess-
ment and Review Instrument (JBI-QARI) [47], and
Mixed Studies Review (MSR) [48] will be employed
for mixed methods and quantitative observational
designs.
Thus, all the authors will independently assess the
final set of studies included according to a predefined
risk of bias scoring key [46]:
– Selection bias: description of random components in
the sequence generation
– Allocation concealment: how foreseeable the
allocation of participants has proven to be
– Performance bias: assessment of measures blinding
study participants and personnel from knowledge of
the intervention a participant would receive
– Attrition bias: assessment of study participants’
withdrawal from the analysis
– Reporting bias: assessment of possible selection in
expected or pre-specified outcomes, deriving from a
systematic difference between reported and non-
reported findings. This will be based on the existence
of a trial protocol and whether the expected out-
comes have been reported in a pre-specified way.
– Other sources of bias: sample size and power
calculations of the trial are based on the reported
outcome or confounding.
Finally, literature will be updated before the publica-
tion draft is issued. Any new, relevant studies will be
added to the review results.
Data analysis
Data from included studies will be extracted and stored
in a customized Excel® spreadsheet. They will be struc-
tured according to the following items: the study setting,
populations, study methods, information on the risk of
bias assessed, and type of outcomes of significance in re-
lation to the review question and specific objectives.
Table 1 MEDLINE concept plan, modified as needed for other databases
N0 Query
1 exp cesarean section /
2 (Ceasarean OR caesarian OR section OR cesarian OR “cesarean section”OR “caesarean section” OR CS OR C-S OR “C Section” OR C-Section OR “ab-
dominal delivery” OR “abdominal deliveries” cesarean birth, cesarian birth, cesarean deliveries, cesarian deliveries, cesarean delivery, cesarian
delivery)
3 1 OR 2
4 (LMIC OR LIC OR “low income” OR Africa OR Asia OR Latin OR “middle income” OR Afghanistan OR Gambia OR Niger OR Benin OR Guinea OR
Rwanda OR “Burkina Faso” OR Burkina OR “Guinea Bisau” OR “Sierra Leone” OR Burundi OR Haiti OR Somalia OR Cambodia OR Korea OR Sudan
OR “Central African Republic” OR centrafica OR Liberia OR Tanzania OR Chad OR Madagascar OR Togo OR Comoros OR Malawi OR Uganda OR
Congo OR Mali OR Zimbabwe OR Eritrea OR Mozambique OR Ethiopia OR Nepal OR Armenia OR Indonesia OR Samoa OR Bangladesh OR Kenya
OR “Sao Tomé and Principe” OR Bhutan OR Kiribati OR Senegal OR Bolivia OR Kosovo OR “Solomon Islands” OR Salomon OR “Cabo Verde” OR
“Cape Verde” Kyrgyz* OR “Sri Lanka” OR Cameroon OR Lao OR Sudan OR Lesotho OR Swaziland OR “Cote Ivoire” OR “Ivory coast” OR Mauritania
OR Syrian OR Djibouti OR Micronesia OR Tajikistan OR Egypt OR Moldova OR Timor OR “El Salvador” OR Salvador OR Morocco OR Ukraine OR
Georgia OR Myanmar OR Uzbekistan OR Ghana OR Nicaragua OR Vanuatu OR Guatemala OR Nigeria OR Vietnam OR Guyana OR Pakistan OR
Palestine OR Gaza OR Honduras OR “Papua New Guinea” OR Papouasie OR Papouasia OR Yemen OR India OR Philippines OR Zambia OR Albania
OR Fiji OR Namibia OR Algeria OR Gabon OR Palau OR Samoa OR Grenada OR Panama OR Angola OR Iran OR Paraguay OR Azerbaijan OR Iraq
OR Peru OR Belarus OR Jamaica OR Romania OR Belize OR Jordan OR Serbia OR Bosnia OR Herzegovina OR Kazakhstan OR “South Africa” OR
Botswana OR Lebanon OR Lucia OR Brazil OR Libya OR Saint Vincent and the Grenadines OR Bulgaria OR Macedonia OR Suriname OR China OR
Chinese OR Malaysia OR Thailand OR Colombia OR Maldives OR Tonga OR “Costa Rica” OR Marshall OR Tunisia OR Cuba OR Mauritius OR Turkey
OR Dominica OR Mexico OR Turkmenistan OR Dominican OR Mongolia OR Tuvalu OR Ecuador OR Montenegro)
5 exp hospital /
6 hospital OR hospitals OR public OR private OR “health center” OR “health centers” OR “medical college” OR “medical colleges” OR “medical
university” OR “medical universities”
7 5 OR 6
8 3 AND 4 AND 7
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We anticipate that the number of studies will be suffi-
cient to allow us to perform a meta-analysis. Therefore,
data will be pooled to this end. Effect size will be pre-
sented as risk ratios (for categorical outcome) or weighted
mean differences (for continuous data), all based on 95%
confidence intervals and two-sided p values for each out-
come. When the effects of clustering are not taken into
account, we will adjust the standard deviations for the de-
sign effect. Heterogeneity will be assessed statistically
using the standard Chi-square, I-squared statistic using
subgroup analyses. The a priori planned subgroup ana-
lyses will consist of (1) ownership (FP vs. NFP vs. public
providers); (2) population groups (i.e., socio-demographic
factors, parity); and eventually (3) the type of hospital (i.e.,
district hospital, tertiary level private hospital). Private
wards in publicly owned hospitals will be kept in the pub-
lic provider category except if, apart from the amenities
that distinguish them, they fall into a different clinical
scheme applicable to their patients. I-squared value
greater than 50% will be considered as indicative of sub-
stantial heterogeneity [40]. Findings from non-RCT stud-
ies will be presented in a narrative form.
Statistical analyses will be based on intention-to-treat
and calculated using the Cochrane statistical package
Review Manager.
Discussion and conclusion
This systematic review aims to synthesize knowledge on
CSD with respect to its epidemiology and materno-fetal
and materno-infant outcome in function of hospital
ownership in LMICs. As there is a wide array of motiva-
tions behind CSD practice, including medical and non-
medical, personal, or system-driven culture, the present
systematic review will assess the effect on a broad range
of outcomes reported so far. An important body of lit-
erature does exist on CSD, including systematic reviews
on more specific themes, but the “global epidemic” of
CSDs, regardless of reported harms, is raising critical
questions internationally. As the development of private
hospitals is found to be among the drivers, this review
will gather updated information from existing literature.
Because this review aims to guide policy-making in
LMICs, we will restrict its scope to evidence concerning
LMICs, where the CSD rate is growing rapidly despite
their fragile healthcare systems and economies.
Additional file
Additional file 1: Preferred Reporting Items for Systematic review and
Meta-Analysis Protocols (PRISMA-P) 2015 checklist: recommended items
to address in a systematic review protocol.
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